What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel...

13
Clemens Wendtner Professor of Medicine & Clinical Director Munich Clinic Schwabing Dept . of Hematology , Oncology , Immunology , Palliative Medicine , Infectious Diseases and Tropical Medicine Academic Teaching Hospital Ludwig - Maximilians - University of Munich Munich , Germany National Healthcare Preparedness Programs, U.S. Department of Health & Human Services, April 14th, 2020 COVID-19 Clinical Rounds: Critical Care - Patient Care and Clinical Operations

Transcript of What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel...

Page 1: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:

Clemens Wendtner

Professor of Medicine

&

Clinical Director

Munich Clinic Schwabing

Dept. of Hematology, Oncology, Immunology, Palliative Medicine,

Infectious Diseases and Tropical Medicine

Academic Teaching Hospital

Ludwig-Maximilians-University of Munich

Munich, Germany

National Healthcare Preparedness Programs, U.S. Department of Health & Human Services, April 14th, 2020

COVID-19 Clinical Rounds:Critical Care - Patient Care and Clinical Operations

Page 2: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 3: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 4: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 5: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 6: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 7: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 8: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 9: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:

Prone position Horovitz index <200 mmHg

vvECMO Horovitz index < 80 mmHg

Page 10: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 11: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:
Page 12: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:

GS-US-540-5773/5774

Page 13: What’s New in CLL: Areas of Focus - Wendtner.pdf · Studieneinschluss, Studienbüro I _ Med, Tel 10.328B, Dres Höchstetter / Seimaier. Hydroxychloroquin +1- Azithromycin. 1m AmHeartAssoc-Statement:

Thank you !

[email protected]